ES
D Oregon Senate · District 17

Sen. Elizabeth Steiner

Contact Email
Compare
Total votes
4,854
all sessions
Attendance
96%
95 missed
Near the chamber average
With party
99%
of cast votes
Higher than 87% of chamber peers
Bipartisan score
0%
crosses aisle rarely
Lower than 91% of chamber peers
Sponsored
309
bills & resolutions
Lower than 85% of chamber peers
Committees
0
assignments
309 bills and resolutions

Sponsored bills

Total
309
Primary
112
Co-sponsor
197
This page
309
matching current filters
Primary HB 3262
In committee · Oregon House · Lead sponsor
Relating to businesses whose employees receive public assistance; providing for revenue raising that requires approval by a three-fifths majority.

Imposes assessment on large employers with employees who receive or who have minor children who receive certain types of public assistance in this state, in amount equal to public assistance paid. Requires that moneys collected are used to support programs for low-income individuals and families. Makes refusal to hire recipient of public assistance or adverse employment action against recipient of public assistance unfair employment practice. Applies to tax years beginning on or after January 1, 2022.

In committee Jul 1, 2019 0 co-sponsors
Primary HB 3349
In committee · Oregon House · Lead sponsor
Relating to tax treatment of mortgage interest; prescribing an effective date.

Disallows, for purposes of personal income taxation, mortgage interest deduction for residence other than taxpayer's principal residence , unless taxpayer sells residence or actively markets residence for sale . Phases out allowable deduction for interest for principal residence based upon income. Disallows deduction for principal residence above threshold amount. Establishes Oregon Housing Opportunity Account. Transfers amount equal to estimated increase in revenue attributable to restrictions on deduction of mortgage interest to accounts in Oregon Housing Fund ] account . Applies to tax years beginning on or after January 1, 2019. Takes effect on 91st day following adjournment sine die.

In committee Jul 1, 2019 0 co-sponsors
Primary SB 872
In committee · Oregon Senate · Lead sponsor
Relating to the cost of prescription drugs.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

In committee Jun 30, 2019 0 co-sponsors
Co-sponsor SB 829
Signed into law · Oregon Senate · Co-sponsor
Relating to wine labeling; and prescribing an effective date.

Requires that, to extent provided by Oregon Liquor Control Commission rules, if appellation of origin on wine label is American viticultural area in Oregon that is in larger American viticultural area, label must also identify larger American viticultural area. Requires commission to make requirement applicable by rule within Willamette Valley viticultural area. Prohibits use of American viticultural area on wine label in manner resembling brand. Creates exception. Applies to wine labeled on or after January 1, 2023. Requires commission to appoint advisory committee. Sunsets advisory committee January 2, 2024. Requires commission to adopt rules establishing penalty schedule for labeling requirement. Requires adoption of initial rules in time to take effect January 1, 2023. Repeals rule adoption requirement January 2, 2024. Requires commission to report to interim committee of Legislative Assembly no later than September 15, 2020, regarding advisory committee recommendations and status of commission rule adoption proceedings. Takes effect on 91st day following adjournment sine die.

Signed into law Jun 21, 2019 1 co-sponsor
Primary SB 638
Signed into law · Oregon Senate · Lead sponsor
Relating to the adoption of research animals.

Requires research facilities that use dogs or cats for laboratory research to offer dogs or cats no longer used for research for adoption prior to euthanasia. Provides that research facility is immune from civil liability for or resulting from transfer of dog or cat, if research facility acted in good faith concerning health and physical condition of dog or cat. Requires certain research facilities to submit annual report to Secretary of State that provides certain information regarding release of dogs and cats and animal shelters with which facilities have entered into written agreements. Provides that reports are confidential and exempt from disclosure except that Secretary of State shall make aggregate data available to public upon request.

Signed into law Jun 21, 2019 0 co-sponsors
Co-sponsor SB 507
Signed into law · Oregon Senate · Co-sponsor
Relating to occupational diseases for purposes of workers' compensation for certain workers; and prescribing an effective date.

Specifies certain presumptions as to cause of ] compensability of covered employee's claim of benefits under workers' compensation law for death, disability or impairment of health of fire service professional, public safety personnel or employee of public or private safety agency with duties related to firefighting, police, ambulance or emergency medical services in claim for benefits related to occupational disease under workers' compensation law ]. Specifies standard of evidence necessary for rebuttal of presumption. Provides that insurer or self-insured employer may later deny compensability of claim if exposure to trauma ceases being of real importance or great consequence in causing disability, impairment of health or need for treatment. Defines "covered employee." Takes effect on 91st day following adjournment sine die.

Signed into law Jun 21, 2019 1 co-sponsor
Showing 161 to 170 of 309 bills
Previous 1 … 16 17 18 … 31 Next